Want to Join Our Team?
Premier Life Sciences Strategy Consulting
We merge the art of innovative thinking with the science of strategic consulting.
Founded in 2012 by industry veterans, Blue Matter has established itself as a leading life sciences strategy consulting firm specializing in the pharmaceutical and biotech sectors. We offer the tools, methodologies, and expertise of a large global consulting firm, while providing the personalized service and creativity of a more agile firm.
We empower life sciences companies to achieve their full potential.
With proven success driving strategy and commercialization forward for some of the world’s most innovative therapies, our client base includes over 250 companies, ranging from start-ups to nearly all of the top 20 global biopharma companies.
By the Numbers
We leverage diverse perspectives and expertise to make a difference.
The Blue Matter team is composed of seasoned industry veterans, life science strategy consultants, and scientists dedicated to driving innovation and delivering impactful results for our clients across the globe.
Join our teamBy the Numbers
We’re at the forefront of industry trends and technological advancements.
Our in-depth understanding of the pharmaceutical and biotech markets in which we operate enables us to offer recommendations that stand up to the realities and nuances of these complex environments.
Read what’s trending
Exploration of Real-World Data Sources in Latin America, Middle East and North Africa, and Asia Pacific, to Support Oncology Evidence Generation: A Targeted Literature Review and Regional Recommendations
June 23, 2026
ASCO 2026: The RAS Revolution Arrives, ADC Era Keeps Expanding, and a New IO Backbone Starts to Take Shape
June 16, 2026
Critical Success Factors for Commercializing Cell & Gene Therapies (5): Supplemental Evidence Generation – Why the Data Story Doesn’t End at Approval
June 16, 2026Our Partners
The Blue Matter family also includes other leading companies that provide specialized support to the biopharmaceutical industry.